Kameel D. Farag Akari Therapeutics PLC (AKTX) insider trading activity

AKTX Quotes by TradingView

Kameel D. Farag is Interim CFO of Akari Therapeutics Plc. Currently has a direct ownership of 26,619 shares of AKTX, which is worth approximately $13,841. The most recent transaction as insider was on Nov 01, 2025, when has been sold 58,619 shares (American Depositary Shares representing Ordinary Shares) at a price of $0.75 per share, resulting in proceeds of $43,964. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.6K
n/a 3M change
n/a 12M change
Total Value Held $13,841

Kameel D. Farag Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2025
BUY
Grant, award, or other acquisition
$43,964 $0.75 p/Share
58,619 Added 68.77%
26,619 American Depositary Sh...
Oct 22 2025
BUY
Grant, award, or other acquisition
$4,644 $0.74 p/Share
6,277 Added 50.0%
6,277 American Depositary Sh...
KDF

Kameel D. Farag

Interim CFO
Tampa, FL

Track Institutional and Insider Activities on AKTX

Follow Akari Therapeutics Plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKTX shares.

Notify only if

Insider Trading

Get notified when an Akari Therapeutics PLC insider buys or sells AKTX shares.

Notify only if

News

Receive news related to Akari Therapeutics Plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKTX